Organizing pneumonia following ocrelizumab use in a patient with multiple sclerosis: A case report
Tuberk Toraks · 10.03.2023 · 71 (1) · 107-111
DOI: 10.5578/tt.20239913 ↗Kurz gefasst
Fallbericht in der Zeitschrift Tuberk Toraks, online erschienen am 11.03.2023. Verfasst von Nurten Aysan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Clinic of Chest Diseases, İstanbul Yedikule Chest Diseases and Thoracic Surgery Training and Research Hospital, İstanbul, Türkiye. Hauptthemen laut MEDLINE: Multiple Sclerosis, Organizing Pneumonia, Pneumonia. Die Arbeit wurde bisher 8-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Clinic of Chest Diseases, İstanbul Yedikule Chest Diseases and Thoracic Surgery Training and Research Hospital, İstanbul, Türkiye.
- Clinic of Chest Diseases, Başakşehir Çam and Sakura City Hospital, İstanbul, Türkiye.
- Department of Chest Diseases, İstanbul Medeniyet University Faculty of Medicine, İstanbul, Türkiye.
Zitieren
APA
Aysan, N., Köybaşı, G., Satıcı, C., Demirkol, M. A., Arpınar Yiğitbaş, B., & Arpaçağ Koşar, A. F. (2023). Organizing pneumonia following ocrelizumab use in a patient with multiple sclerosis: A case report. Tuberk Toraks, 71(1), 107-111. https://doi.org/10.5578/tt.20239913
Vancouver
Aysan N, Köybaşı G, Satıcı C, Demirkol MA, Arpınar Yiğitbaş B, Arpaçağ Koşar AF. Organizing pneumonia following ocrelizumab use in a patient with multiple sclerosis: A case report. Tuberk Toraks. 2023;71(1):107-111. doi:10.5578/tt.20239913
BibTeX
@article{Aysan2023,
author = {Aysan, Nurten and Köybaşı, Gizem and Satıcı, Celal and Demirkol, Mustafa Asım and Arpınar Yiğitbaş, Burcu and Arpaçağ Koşar, Ayşe Filiz},
title = {Organizing pneumonia following ocrelizumab use in a patient with multiple sclerosis: A case report},
journal = {Tuberk Toraks},
year = {2023},
volume = {71},
number = {1},
pages = {107--111},
doi = {10.5578/tt.20239913}
}
EUVIMED